Hepatectomy for Resectable Colorectal Cancer Metastases-Indicators of Prognosis, Definition of Resectability, Techniques and Outcomes

Surgical Oncology Clinics of North America

Volumn 16, Issue 3, 2007, Pages 493-506

  Lupinacci, Renato ^a   Penna, Christophe ^a   Nordlinger, Bernard ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; OXALIPLATIN;

COLORECTAL CANCER; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER RESECTION; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REOPERATION; TREATMENT OUTCOME;

EID: 34250803443     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.04.014     Document Type: Review

References (50)

1. Fong Y., Kemeny N., Paty P., et al. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 12 (1996) 219-252
2. Steele G.J., and Ravikumar T.S. Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg 210 (1989) 127-138
3. Scheele J., Stangl R., and Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
4. Adson M.A., van Heerden J.A., Adson M.H., et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 119 (1984) 647-651
5. Bilchik A.J., Postone G., Curley S.A., et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 23 (2005) 9073-9078
6. Rubbia-Brandt L., Audard V., Sartoretti P., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15 (2004) 460-466
7. Kooby D.A., Fong Y., Suriawinata A., et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7 (2003) 1034-1044
8. Fernandez F.G., Ritter J., Goodwin J.W., et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200 (2005) 845-853
9. Karoui M., Penna C., Amin-Hashem M., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243 (2006) 1-7
10. Vauthey J.N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
11. Parikh A.A., Gentner B., Wu T.T., et al. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7 (2003) 1082-1088
12. Aloia Aloia T., Sebagh M., Plasse M., et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24 (2006) 4983-4990
13. Scholmerich J., Volk B.A., and Gerok W. Value and limitations of abdominal ultrasound in tumor staging-liver metastasis and lymphoma. Eur J Radiol 7 (1987) 243-245
14. Hagspiel K.D., Neidl K.F., Eichenberger A.C., et al. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5T with dynamic CT, intraoperative US and percutaneous US. Radiology 196 (1995) 471-478
15. Konopke R., Kersting S., Bergert H., et al. Contrast-enhanced ultrasonography to detect liver metastases: a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 22 (2007) 201-207
16. Zerhouni E.A., Rutter C., Hamilton S.R., et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 200 (1996) 443-451
17. Starzl T.E., Iwatsuki S., and Shaw B. Left hepatic trisegmentectomy. Surg Gynecol Obstet 155 (1982) 21-27
18. Rahusen F.D., Cuesta M.A., Borgstein P.J., et al. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 230 (1999) 31-37
19. Bloed W., van Leeuwen M.S., and Borel Rinks I.H. Role of intraoperative ultrasound of the liver with improved preoperative hepatic imaging. Eur J Surg 166 (2000) 691-695
20. Bismuth H., Houssin D., and Castaing D. Major and minor segmentectomies "réglées" in liver surgery. World J Surg 6 (1982) 10-24
21. Starzl T.E., Bell R.H., Beart R.W., et al. Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 141 (1975) 429-437
22. Kokudo N., Tada K., Seki M., et al. Anatomical major resections versus nonanatomical limited resections for liver metastases from colorectal carcinoma. Am J Surg 181 (2001) 153-159
23. Benoist S., Brouquet A., Penna C., et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 24 (2006) 3939-3945
24. Bengtsson G., Carlsson G., Hafstrom L., et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141 (1981) 586-589
25. Lambert L.A., Colacchio T.A., and Barth Jr. R.J. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 135 (2000) 473-480
26. Nordlinger B., Jaeck D., Guiguet M., et al. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B., and Jaeck D. (Eds). Treatment of hepatic metastases of colorectal cancer (1992), Springer-Verlag, Paris 129-146
27. Tanaka K., Shimada H., Matsuo K., et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136 (2004) 650-659
28. Weber J.C., Bachellier P., Oussoultzoglou E., et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 90 (2003) 956-962
29. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236 (2002) 397-407
30. Clavien P.A., Selzner M., Rudiger H.A., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238 (2003) 843-852
31. Delva E., Camus Y., Nordlinger B., et al. Vascular occlusion for liver resection. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 209 (1989) 211-218
32. Belghiti J., Kabbej M., Sauvanet A., et al. Drainage after elective hepatic resection. A randomized trial. Ann Surg 218 (1993) 748-753
33. Gigot J.F., Glineur D., Santiago Azagra J., et al. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 236 (2002) 753-762
34. Cherqui D., Husson E., Hammoud R., et al. Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg 232 (2000) 753-762
35. Vibert E., Pernicerni T., Levard H., et al. Laparoscopic liver resection. Br J Surg 93 (2006) 67-72
36. Doci R., German L., Bigmani P., et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinant. Br J Surg 78 (1991) 797-801
37. Fong Y., Cohen A.M., Fortner J.G., et al. Liver resection for colorectal metastases. J Clin Oncol 15 (1997) 938-946
38. Scheele J., Stangl R., Altendorf-Hofmann A., et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110 (1991) 13-29
39. Nordlinger B., Quilichini M.A., Parc R., et al. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann Surg 205 (1987) 256-263
40. Scheele J., Stang R., Altendorf-Hofmann A., et al. Resection of colorectal liver metastases. World J Surg 19 (1995) 59-71
41. Jamison R.L., Donohue J.H., Nagorney D.M., et al. Hepatic resections for metastatic colorectal cancer. Results in cure for some patients. Arch Surg 132 (1997) 505-511
42. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
43. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg 231 (2000) 487-499
44. Tanaka K., Shimada H., Ohta M., et al. Procedures of choice for resection of primary and recurrent liver metastases from colorectal câncer. World J Surg 28 (2004) 482-487
45. Pawlik T., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 (2005) 715-724
46. Laurent C., Sa Cunha A., Rullier E., et al. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastases. J Am Coll Surg 198 (2004) 884-891
47. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77 (1996) 1254-1262
48. Sasaki A., Iwashita Y., Shibata K., et al. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg 9 (2005) 374-380
49. Lange J.F., Leese T., Castaing D., et al. Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet 169 (1989) 119-126
50. Shaw I.M., Rees M., Welsh F.K.S., et al. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 93 (2006) 457-464